Advertisement

Topics

With all the debate around $GBT, this FDA-ASH #SickleCell Disease (SCD) Clinical Endpoints Workshop on October 17-18 will be an important event to watch. Co-chaired by FDA DHP director Ann Farrell. http://www.hematology.org/Meetings/8840.aspx … Also

09:10 EDT 14 Sep 2018 | Andy Biotech

With all the debate around , this FDA-ASH Disease (SCD) Clinical Endpoints Workshop on October 17-18 will be an important event to watch. Co-chaired by FDA DHP director Ann Farrell. http://www.hematology.org/Meetings/8840.aspx … Also relevant for etc h/t

Original Article: With all the debate around $GBT, this FDA-ASH #SickleCell Disease (SCD) Clinical Endpoints Workshop on October 17-18 will be an important event to watch. Co-chaired by FDA DHP director Ann Farrell. http://www.hematology.org/Meetings/8840.aspx … Also

NEXT ARTICLE

More From BioPortfolio on "With all the debate around $GBT, this FDA-ASH #SickleCell Disease (SCD) Clinical Endpoints Workshop on October 17-18 will be an important event to watch. Co-chaired by FDA DHP director Ann Farrell. http://www.hematology.org/Meetings/8840.aspx … Also "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...